AR078555A1 - Polimorfos de pardoprunox - Google Patents
Polimorfos de pardoprunoxInfo
- Publication number
- AR078555A1 AR078555A1 ARP100103655A ARP100103655A AR078555A1 AR 078555 A1 AR078555 A1 AR 078555A1 AR P100103655 A ARP100103655 A AR P100103655A AR P100103655 A ARP100103655 A AR P100103655A AR 078555 A1 AR078555 A1 AR 078555A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- refers
- methods
- preparing
- receptor agonist
- Prior art date
Links
- YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 title 1
- 229950010798 pardoprunox Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- NQRIKTDKFHAOKC-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one;hydrochloride Chemical compound Cl.C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 NQRIKTDKFHAOKC-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 229940096895 Dopamine D2 receptor agonist Drugs 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 206010033664 Panic attack Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002288 dopamine 2 receptor stimulating agent Substances 0.000 abstract 1
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 1
- 208000037870 generalized anxiety Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 230000000862 serotonergic effect Effects 0.000 abstract 1
- 239000000952 serotonin receptor agonist Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Se refiere a un proceso novedoso para la preparacion de clorhidrato de 7-(4-metil-1-piperazinil)benzoxazol-2(3H)-ona, un agonista del receptor de la dopamina-D2 parcial y un agonista del receptor de la serotonina 5-HT1A total. La solicitud también se refiere a las formas polimorficas de dicho compuesto, como así también a las composiciones farmacéuticas que contienen estos compuestos, a los métodos para preparar los compuestos, los métodos para preparar intermediarios novedosos utiles para su síntesis, y los métodos para preparar las composiciones. La solicitud también se refiere a los usos de dichos compuestos y composiciones, en particular a su uso para administrarlos a paciente para alcanzar un efecto terapéutico en las afecciones o enfermedades del sistema nervioso central, causadas por alteraciones de los sistemas dopaminérgicos y/o serotonérgicos, por ejemplo: trastornos de ansiedad (con inclusion de ansiedad generalizada, ataque de pánico y trastorno obsesivo compulsivo), depresion, autismo, esquizofrenia, enfermedad de Parkinson, síndrome de las piernas inquietas, alteraciones del conocimiento y la memoria.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09172802 | 2009-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR078555A1 true AR078555A1 (es) | 2011-11-16 |
Family
ID=42028109
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100103655A AR078555A1 (es) | 2009-10-12 | 2010-10-07 | Polimorfos de pardoprunox |
| ARP100103656A AR078556A1 (es) | 2009-10-12 | 2010-10-07 | Monohidrato de pardoprunox |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100103656A AR078556A1 (es) | 2009-10-12 | 2010-10-07 | Monohidrato de pardoprunox |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20110251214A1 (es) |
| EP (1) | EP2488181A1 (es) |
| JP (1) | JP2013507420A (es) |
| AR (2) | AR078555A1 (es) |
| AU (1) | AU2010305834A1 (es) |
| CA (1) | CA2777305A1 (es) |
| TW (2) | TW201118090A (es) |
| UY (2) | UY32935A (es) |
| WO (2) | WO2011045267A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA71590C2 (en) | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
| AR034206A1 (es) | 2001-02-16 | 2004-02-04 | Solvay Pharm Bv | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos |
| US7786126B2 (en) * | 2006-06-16 | 2010-08-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising SLV308 and a dopamine agonist |
-
2010
- 2010-10-06 UY UY0001032935A patent/UY32935A/es not_active Application Discontinuation
- 2010-10-06 UY UY0001032934A patent/UY32934A/es not_active Application Discontinuation
- 2010-10-07 AR ARP100103655A patent/AR078555A1/es unknown
- 2010-10-07 AR ARP100103656A patent/AR078556A1/es unknown
- 2010-10-08 TW TW099134368A patent/TW201118090A/zh unknown
- 2010-10-08 TW TW099134367A patent/TW201118089A/zh unknown
- 2010-10-10 US US12/901,543 patent/US20110251214A1/en not_active Abandoned
- 2010-10-10 US US12/901,542 patent/US20110086862A1/en not_active Abandoned
- 2010-10-11 CA CA2777305A patent/CA2777305A1/en not_active Abandoned
- 2010-10-11 EP EP10765427A patent/EP2488181A1/en not_active Withdrawn
- 2010-10-11 WO PCT/EP2010/065186 patent/WO2011045267A1/en not_active Ceased
- 2010-10-11 WO PCT/EP2010/065191 patent/WO2011045270A1/en not_active Ceased
- 2010-10-11 AU AU2010305834A patent/AU2010305834A1/en not_active Abandoned
- 2010-10-11 JP JP2012533598A patent/JP2013507420A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011045267A1 (en) | 2011-04-21 |
| US20110251214A1 (en) | 2011-10-13 |
| AR078556A1 (es) | 2011-11-16 |
| UY32934A (es) | 2011-05-31 |
| TW201118089A (en) | 2011-06-01 |
| UY32935A (es) | 2011-05-31 |
| AU2010305834A1 (en) | 2012-06-07 |
| CA2777305A1 (en) | 2011-04-21 |
| JP2013507420A (ja) | 2013-03-04 |
| TW201118090A (en) | 2011-06-01 |
| WO2011045270A1 (en) | 2011-04-21 |
| EP2488181A1 (en) | 2012-08-22 |
| US20110086862A1 (en) | 2011-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP13012892A (es) | IMIDAZO[5,1-f][1,2,4]TRIAZINAS PARA EL TRATAMIENTO DE TRASTORNOS NEUROLÓGICOS | |
| BRPI1007018B8 (pt) | composto ligante de receptores de adenosina, composição farmacêutica, e, uso de um composto. | |
| BRPI0415657A (pt) | derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c | |
| ECSP10010209A (es) | Agonistas novedosos de los receptores de glucocorticoides | |
| CL2011000137A1 (es) | Uso de compuestos derivados de 4,5-dihidro-oxazol-2-ilamina para tratar trastornos de ansiedad, trastornos bipolar, esquizofrenia, enfermedades neurológicas, epilepsias, migraña, trastornos metabólicos, trastornos cardiovasculares, entre otros; compuestos derivados de 4,5-dihidroxazol-2-ilamino; proceso de síntesis | |
| PA8815001A1 (es) | Piridinil amidas para el tratamiento de trastornos del snc y metabolicos | |
| CL2008002864A1 (es) | Compuestos derivados de 2-amino-quinolina, antagonistas del receptor de serotonina 5-ht 5a; procedimiento de preparacion;composicion farmaceutica; y uso de los compuestos en la prevencion o el tratamiento de depresion,trastornos de ansiedad,esquizofrenia,trastornos de panico,trastornos de memoria,demencia,entre otros. | |
| RU2018130727A (ru) | Органические соединения | |
| UY30330A1 (es) | Nuevas formas polimorfas de (2s)-(4e)-n-metil-5-(3-(5-isopropoxipiridin)il)-4-penten-2-amina | |
| AR067662A1 (es) | Derivados de benzo[d]isoxazol-3-il-piperidina, medicamentos que los contienen y usos terapeuticos para enfermedades asociadas al sistema nervioso. | |
| AR065128A1 (es) | Derivados de 2-aminooxazolinas como ligandos taar1. procesos de obtencion, composiciones farmaceuticas y usos | |
| NI200700270A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
| UY28876A1 (es) | Compuestos de morfolina sustituida y composiciones para el tratamiento de trastornos del sistema nervioso central | |
| UY30783A1 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona, procesos para su preparacion y su uso como agentes farmacéuticos | |
| AR096640A1 (es) | Derivados de indolin-2-ona o pirrolo-piridin / pirimidin-2-ona | |
| BRPI0607532A2 (pt) | derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c | |
| CL2012000185A1 (es) | Compuestos derivados de oxazina o oxazepina, inhibidores de bace; composicion farmaceutica que los comprende; combinacion farmaceutica; y su uso para el tratamiento del deterioro cognitivo, neuropatia amiloide, o enfermedad de alzheimer. | |
| HRP20151334T1 (hr) | Derivat kateholamina koristan u lijeäśenju parkinsonove bolesti | |
| BRPI0415769A (pt) | alcanaminas de diidrobenzofuranila e composições farmacêuticas contendo-as | |
| AR075626A1 (es) | Metodos para administrar (4ar,10ar)-1-n- propil-1,2,3,4,4a,5,10,10a- octahidro -benzo (g) quinolin-6,7-diol y sus composiciones farmaceuticas. uso. | |
| UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
| DOP2012000032A (es) | DERIVADOS DE AMIDAS ESPIROCÍCLICAS QUE POSSEN ACTIVIDAD EN LOS RECEPTORES MUSCARINICOS Y RECPETORES ß2 | |
| CL2011000184A1 (es) | Compuestos derivados de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno; agonista de receptores de melatonina; proceso para la preparacion de los compuestos; composicion farmaceutica que comprende a los compuestos; y su uso de los compuestos en la preparacion de medicamentos. | |
| AR079103A1 (es) | Compuesto de sal de mesilato de (s) -2-(4-(3-fluoro-benciloxi)-bencilamino)-propionamida, forma polimorfica (nf6) , composicion farmaceutica, uso del mismo para la preparacion de un medicamento y su procesos de preparacion | |
| UY30529A1 (es) | Compuestos de 1h-quinolin-4-ona, procedimientos, usos y composiciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |